Shyam Sunder Verma

Title: Shyam Sunder Verma: Innovator in Pharmaceutical Chemistry

Introduction

Shyam Sunder Verma is a notable inventor based in Varanasi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and processes. With a total of 2 patents to his name, Verma's work is recognized for its potential impact on cancer treatment.

Latest Patents

Verma's latest patents include a crystalline form of afatinib dimaleate. This invention provides a crystalline Form I of afatinib dimaleate, along with its preparation process and pharmaceutical composition. It is particularly useful in the treatment of metastatic non-small cell lung cancer. Another significant patent is the process for the preparation of 4-dimethylaminocrotonic acid. This invention outlines a method for producing 4-dimethylaminocrotonic acid or its salts, which serve as intermediates for the preparation of afatinib or its salts.

Career Highlights

Shyam Sunder Verma is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Sun Pharmaceutical has allowed him to focus on innovative drug development and contribute to advancements in cancer therapies.

Collaborations

Verma has collaborated with several professionals in his field, including Shravan Kumar Singh and Kaptan Singh. These collaborations have fostered a productive environment for research and development, enhancing the quality and scope of their work.

Conclusion

Shyam Sunder Verma's contributions to pharmaceutical chemistry, particularly in cancer treatment, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and providing new solutions for patients.